Jaimie Z Shing

AAPC average annual percentage change APC annual percentage change ASIR age-standardized incidence rate CI confidence interval HPV human papillomavirus ICD international classification of diseases IR incidence rate LR linear regression NHLS National Health Laboratory Services of South Africa SCC squamous cell carcinoma 1 INTRODUCTION Racial differences in HIV and human papillomavirus (HPV) prevalence and socioeconomic status could lead to substantive differences in HPV-associated cancer rates...

INTRODUCTION Over the past two decades in the United States, the age-standardized incidence rate of multiple myeloma (MM) increased from 5.8/100 000 in 2000 to 6.9/100 000 in 2019, while the age-standardized death rate decreased from 3.8/100 000 in 2000 to 3.1/100 000 in 2019.1 Although MM remains incurable with conventional treatment, the introduction of autologous haematopoietic stem cell transplantation in the 1990s and novel therapeutics over the past two decades have contributed to the...

Abstract The AS04-adjuvanted human papillomavirus (HPV)16/18 vaccine, an L1-based vaccine, provides strong vaccine efficacy (VE) against vaccine-targeted type infections, and partial cross-protection to phylogenetically-related types, which may be affected by variant-level heterogeneity.